Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
NCT06631365Phase 2Recruiting
Phase 2, randomised, open-label trial (2 arms), sponsored by Heluna Health. Primary endpoints: Acceptability of the PrEPsmart mobile app at 6 months and Usability of the PrEPsmart mobile app at 6 months. Started Oct 2023; status: recruiting.
Beyond the preview
Study design, results and competitive context are available in the Gosset platform where reported.
Available in the Gosset platform where reported.
Available in the Gosset platform where reported.
See how Gosset can support your research on NCT06631365.